Role of endogenous cholecystokinin on growth of human pancreatic cancer

Gail Matters, Christopher McGovern, John F. Harms, Kevin Markovic, Krystal Anson, Calpurnia Jayakumar, Melissa Sasso, Christina Awad, Jill P. Smith

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cholecystokinin (CCK) and gastrin stimulate growth of pancreatic cancer. Although down-regulation of gastrin inhibits growth of pancreatic cancer, the contribution of endogenous CCK to tumor growth is unknown. The purpose of this study was to evaluate the role of endogenous CCK on autocrine growth of pancreatic cancer. Pancreatic cancer cell lines were analyzed for CCK mRNA and peptide expression by real-time RT-PCR and radioimmunoassay, respectively. The effect of endogenous CCK on growth was evaluated by treating cancer cells with CCK neutralizing antibodies and by down-regulating CCK mRNA by RNAi. Wild-type pancreatic cancer cells expressed significantly lower CCK mRNA and peptide levels than gastrin. Neither treatment of pancreatic cancer cells with CCK antibodies nor the down-regulation of CCK mRNA and peptide by shRNAs altered growth in vitro or in vivo. Conversely, when gastrin mRNA expression was down-regulated, the same cells failed to produce tumors in spite of having sustained levels of endogenous CCK. Pancreatic cancer cells produce CCK and gastrin; however, the autocrine production of gastrin is more important for stimulating tumor growth.

Original languageEnglish (US)
Pages (from-to)593-601
Number of pages9
JournalInternational journal of oncology
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2011

Fingerprint

Cholecystokinin
Pancreatic Neoplasms
Gastrins
Growth
Messenger RNA
Peptides
Neoplasms
Down-Regulation
RNA Interference
Neutralizing Antibodies
Radioimmunoassay
Real-Time Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Matters, G., McGovern, C., Harms, J. F., Markovic, K., Anson, K., Jayakumar, C., ... Smith, J. P. (2011). Role of endogenous cholecystokinin on growth of human pancreatic cancer. International journal of oncology, 38(3), 593-601. https://doi.org/10.3892/ijo.2010.886
Matters, Gail ; McGovern, Christopher ; Harms, John F. ; Markovic, Kevin ; Anson, Krystal ; Jayakumar, Calpurnia ; Sasso, Melissa ; Awad, Christina ; Smith, Jill P. / Role of endogenous cholecystokinin on growth of human pancreatic cancer. In: International journal of oncology. 2011 ; Vol. 38, No. 3. pp. 593-601.
@article{93850a6c8b9f4f9d8c23887d8c0ee997,
title = "Role of endogenous cholecystokinin on growth of human pancreatic cancer",
abstract = "Cholecystokinin (CCK) and gastrin stimulate growth of pancreatic cancer. Although down-regulation of gastrin inhibits growth of pancreatic cancer, the contribution of endogenous CCK to tumor growth is unknown. The purpose of this study was to evaluate the role of endogenous CCK on autocrine growth of pancreatic cancer. Pancreatic cancer cell lines were analyzed for CCK mRNA and peptide expression by real-time RT-PCR and radioimmunoassay, respectively. The effect of endogenous CCK on growth was evaluated by treating cancer cells with CCK neutralizing antibodies and by down-regulating CCK mRNA by RNAi. Wild-type pancreatic cancer cells expressed significantly lower CCK mRNA and peptide levels than gastrin. Neither treatment of pancreatic cancer cells with CCK antibodies nor the down-regulation of CCK mRNA and peptide by shRNAs altered growth in vitro or in vivo. Conversely, when gastrin mRNA expression was down-regulated, the same cells failed to produce tumors in spite of having sustained levels of endogenous CCK. Pancreatic cancer cells produce CCK and gastrin; however, the autocrine production of gastrin is more important for stimulating tumor growth.",
author = "Gail Matters and Christopher McGovern and Harms, {John F.} and Kevin Markovic and Krystal Anson and Calpurnia Jayakumar and Melissa Sasso and Christina Awad and Smith, {Jill P.}",
year = "2011",
month = "3",
day = "1",
doi = "10.3892/ijo.2010.886",
language = "English (US)",
volume = "38",
pages = "593--601",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "3",

}

Matters, G, McGovern, C, Harms, JF, Markovic, K, Anson, K, Jayakumar, C, Sasso, M, Awad, C & Smith, JP 2011, 'Role of endogenous cholecystokinin on growth of human pancreatic cancer', International journal of oncology, vol. 38, no. 3, pp. 593-601. https://doi.org/10.3892/ijo.2010.886

Role of endogenous cholecystokinin on growth of human pancreatic cancer. / Matters, Gail; McGovern, Christopher; Harms, John F.; Markovic, Kevin; Anson, Krystal; Jayakumar, Calpurnia; Sasso, Melissa; Awad, Christina; Smith, Jill P.

In: International journal of oncology, Vol. 38, No. 3, 01.03.2011, p. 593-601.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of endogenous cholecystokinin on growth of human pancreatic cancer

AU - Matters, Gail

AU - McGovern, Christopher

AU - Harms, John F.

AU - Markovic, Kevin

AU - Anson, Krystal

AU - Jayakumar, Calpurnia

AU - Sasso, Melissa

AU - Awad, Christina

AU - Smith, Jill P.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Cholecystokinin (CCK) and gastrin stimulate growth of pancreatic cancer. Although down-regulation of gastrin inhibits growth of pancreatic cancer, the contribution of endogenous CCK to tumor growth is unknown. The purpose of this study was to evaluate the role of endogenous CCK on autocrine growth of pancreatic cancer. Pancreatic cancer cell lines were analyzed for CCK mRNA and peptide expression by real-time RT-PCR and radioimmunoassay, respectively. The effect of endogenous CCK on growth was evaluated by treating cancer cells with CCK neutralizing antibodies and by down-regulating CCK mRNA by RNAi. Wild-type pancreatic cancer cells expressed significantly lower CCK mRNA and peptide levels than gastrin. Neither treatment of pancreatic cancer cells with CCK antibodies nor the down-regulation of CCK mRNA and peptide by shRNAs altered growth in vitro or in vivo. Conversely, when gastrin mRNA expression was down-regulated, the same cells failed to produce tumors in spite of having sustained levels of endogenous CCK. Pancreatic cancer cells produce CCK and gastrin; however, the autocrine production of gastrin is more important for stimulating tumor growth.

AB - Cholecystokinin (CCK) and gastrin stimulate growth of pancreatic cancer. Although down-regulation of gastrin inhibits growth of pancreatic cancer, the contribution of endogenous CCK to tumor growth is unknown. The purpose of this study was to evaluate the role of endogenous CCK on autocrine growth of pancreatic cancer. Pancreatic cancer cell lines were analyzed for CCK mRNA and peptide expression by real-time RT-PCR and radioimmunoassay, respectively. The effect of endogenous CCK on growth was evaluated by treating cancer cells with CCK neutralizing antibodies and by down-regulating CCK mRNA by RNAi. Wild-type pancreatic cancer cells expressed significantly lower CCK mRNA and peptide levels than gastrin. Neither treatment of pancreatic cancer cells with CCK antibodies nor the down-regulation of CCK mRNA and peptide by shRNAs altered growth in vitro or in vivo. Conversely, when gastrin mRNA expression was down-regulated, the same cells failed to produce tumors in spite of having sustained levels of endogenous CCK. Pancreatic cancer cells produce CCK and gastrin; however, the autocrine production of gastrin is more important for stimulating tumor growth.

UR - http://www.scopus.com/inward/record.url?scp=79952015540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952015540&partnerID=8YFLogxK

U2 - 10.3892/ijo.2010.886

DO - 10.3892/ijo.2010.886

M3 - Article

C2 - 21186400

AN - SCOPUS:79952015540

VL - 38

SP - 593

EP - 601

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 3

ER -